SGLT2 inhibition and COVID-19: The road not taken.

Das, Liza; Dutta, Pinaki

Das, Liza; Dutta, Pinaki.

Das L; Department of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Dutta P; Department of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Eur J Clin Invest ; 50(12): e13339, 2020 Dec.

Article in English | MEDLINE | ID: covidwho-640283

Subject(s)

COVID-19 Drug Treatment; Cardiovascular Diseases/drug therapy; Diabetes Mellitus/drug therapy; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use; Acute Kidney Injury/physiopathology; COVID-19/physiopathology; Cardiovascular Diseases/physiopathology; Diabetes Mellitus/physiopathology; Humans; Sodium-Hydrogen Exchangers/antagonists & inhibitors

Keywords

ACE2; COVID-19; SGLT2 inhibitors; cytokine storm; sodium hydrogen exchanger

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus / Sodium-Glucose Transporter 2 Inhibitors / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Eur J Clin Invest Year: 2020 Document Type: Article Affiliation country: Eci.13339

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google